167 related articles for article (PubMed ID: 31136207)
41. Anti-TNF therapy is not associated with an increased risk of post-colectomy complications, a population-based study.
Ward ST; Mytton J; Henderson L; Amin V; Tanner JR; Evison F; Radley S
Colorectal Dis; 2018 May; 20(5):416-423. PubMed ID: 29059479
[TBL] [Abstract][Full Text] [Related]
42. Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative Colitis.
Hyams JS; Brimacombe M; Haberman Y; Walters T; Gibson G; Mo A; Mack D; Griffiths A; Boyle B; LeLeiko N; Markowitz J; Rosh J; Patel A; Shah S; Baldassano R; Pfefferkorn M; Sauer C; Dailey J; Venkateswaran S; Kugathasan S; Denson LA
Inflamm Bowel Dis; 2022 Feb; 28(2):151-160. PubMed ID: 33904583
[TBL] [Abstract][Full Text] [Related]
43. Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.
Dean KE; Hikaka J; Huakau JT; Walmsley RS
J Gastroenterol Hepatol; 2012 Mar; 27(3):487-92. PubMed ID: 22098019
[TBL] [Abstract][Full Text] [Related]
44. Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry.
Ordás I; Domènech E; Mañosa M; García-Sánchez V; Iglesias-Flores E; Rodríguez-Moranta F; Márquez L; Merino O; Fernández-Bañares F; Gomollón F; Vera M; Gutiérrez A; LLaó J; Gisbert JP; Aguas M; Arias L; Rodríguez-Lago I; Muñoz C; Alcaide N; Calvet X; Rodríguez C; Montoro MA; García S; De Castro ML; Piqueras M; Pareja L; Ribes J; Panés J; Esteve M;
Am J Gastroenterol; 2018 Jul; 113(7):1009-1016. PubMed ID: 29713028
[TBL] [Abstract][Full Text] [Related]
45. Healthcare resource utilization and treatment costs of Finnish chronic inflammatory bowel disease patients treated with infliximab
Ylisaukko-Oja T; Torvinen S; Ventola H; Schmidt S; Herrala S; Kononoff J; Voutilainen M
Scand J Gastroenterol; 2019 Jun; 54(6):726-732. PubMed ID: 31203693
[No Abstract] [Full Text] [Related]
46. Short- and long-term efficacy of adalimumab salvage therapy after failure of calcineurin inhibitors in steroid-refractory ulcerative colitis.
Nishio M; Ishii Y; Hashimoto Y; Otake H; Ogashiwa T; Tsuda S; Yasuhara H; Saigusa Y; Kimura H; Maeda S; Kunisaki R
Scand J Gastroenterol; 2018; 53(10-11):1236-1244. PubMed ID: 30353757
[TBL] [Abstract][Full Text] [Related]
47. Infliximab for hospitalized patients with severe ulcerative colitis.
Regueiro M; Curtis J; Plevy S
J Clin Gastroenterol; 2006 Jul; 40(6):476-81. PubMed ID: 16825928
[TBL] [Abstract][Full Text] [Related]
48. Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
Kopylov U; Papamichael K; Katsanos K; Waterman M; Bar-Gil Shitrit A; Boysen T; Portela F; Peixoto A; Szilagyi A; Silva M; Maconi G; Har-Noy O; Bossuyt P; Mantzaris G; Barreiro de Acosta M; Chaparro M; Christodoulou DK; Eliakim R; Rahier JF; Magro F; Drobne D; Ferrante M; Sonnenberg E; Siegmund B; Muls V; Thurm T; Yanai H; Dotan I; Raine T; Levin A; Israeli E; Ghalim F; Carbonnel F; Vermeire S; Ben-Horin S; Roblin X
Inflamm Bowel Dis; 2017 Sep; 23(9):1605-1613. PubMed ID: 28590343
[TBL] [Abstract][Full Text] [Related]
49. Infliximab and complications after colectomy in patients with ulcerative colitis.
Bregnbak D; Mortensen C; Bendtsen F
J Crohns Colitis; 2012 Apr; 6(3):281-6. PubMed ID: 22405163
[TBL] [Abstract][Full Text] [Related]
50. Infliximab efficacy in pediatric ulcerative colitis.
Eidelwein AP; Cuffari C; Abadom V; Oliva-Hemker M
Inflamm Bowel Dis; 2005 Mar; 11(3):213-8. PubMed ID: 15735427
[TBL] [Abstract][Full Text] [Related]
51. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006.
Jakobovits SL; Jewell DP; Travis SP
Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506
[TBL] [Abstract][Full Text] [Related]
52. Colectomy rate in ulcerative colitis 15 years after diagnosis: Results from the 2001-2003 Navarra cohort.
Rodríguez C; Elosua A; Prieto C; Pérez E; Irisarri R; Campillo A; Rubio S; Nantes Ó; Angós R; Zozaya JM
Gastroenterol Hepatol; 2022 Jan; 45(1):1-8. PubMed ID: 33545242
[TBL] [Abstract][Full Text] [Related]
53. Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.
Kohn A; Prantera C; Pera A; Cosintino R; Sostegni R; Daperno M
Dig Liver Dis; 2002 Sep; 34(9):626-30. PubMed ID: 12405248
[TBL] [Abstract][Full Text] [Related]
54. Ulcerative colitis-associated hospitalization costs: a population-based study.
Coward S; Heitman SJ; Clement F; Hubbard J; Proulx MC; Zimmer S; Panaccione R; Seow C; Leung Y; Datta I; Ghosh S; Myers RP; Swain M; Kaplan GG
Can J Gastroenterol Hepatol; 2015 Oct; 29(7):357-62. PubMed ID: 26079072
[TBL] [Abstract][Full Text] [Related]
55. Efficacy and safety of infliximab as rescue therapy for ulcerative colitis refractory to tacrolimus.
Yamamoto S; Nakase H; Matsuura M; Honzawa Y; Masuda S; Inui K; Chiba T
J Gastroenterol Hepatol; 2010 May; 25(5):886-91. PubMed ID: 20546441
[TBL] [Abstract][Full Text] [Related]
56. Observational study on the efficacy of adalimumab for the treatment of ulcerative colitis and predictors of outcome.
García-Bosch O; Gisbert JP; Cañas-Ventura A; Merino O; Cabriada JL; García-Sánchez V; Gutiérrez A; Nos P; Peñalva M; Hinojosa J; García-Planella E; Muñoz F; Calvet X; Panés J
J Crohns Colitis; 2013 Oct; 7(9):717-22. PubMed ID: 23142005
[TBL] [Abstract][Full Text] [Related]
57. Impact of Changing Treatment Strategies on Outcomes in Pediatric Ulcerative Colitis.
Bolia R; Rajanayagam J; Hardikar W; Alex G
Inflamm Bowel Dis; 2019 Oct; 25(11):1838-1844. PubMed ID: 31002341
[TBL] [Abstract][Full Text] [Related]
58. Operative indications for patients with refractory or severe ulcerative colitis.
Tsujikawa T; Andoh A; Sakaki M; Ishizuka I; Araki Y; Koyama S; Fujiyama Y
Hepatogastroenterology; 2005; 52(65):1470-3. PubMed ID: 16201099
[TBL] [Abstract][Full Text] [Related]
59. Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis.
Volonaki E; Mutalib M; Kiparissi F; Shah N; Lindley KJ; Elawad M
Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1425-8. PubMed ID: 26426835
[TBL] [Abstract][Full Text] [Related]
60. Performance of tacrolimus in hospitalized patients with steroid-refractory acute severe ulcerative colitis.
Hoffmann P; Wehling C; Krisam J; Pfeiffenberger J; Belling N; Gauss A
World J Gastroenterol; 2019 Apr; 25(13):1603-1617. PubMed ID: 30983820
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
